Nasdaq Drops Over 300 Points; Crude Oil Down 1.5%
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 300 points.
FDA Slaps Clinical Hold On Miromatrix’s For Bioengineered Liver Platform
The FDA has placed a clinical hold on Miromatrix Medical Inc’s (NASDAQ:MIRO) miroliverELAP Investigational New Drug (IND) application for acute liver failure.…
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Piper Sandler Initiates Coverage On Miromatrix Medical with Overweight Rating, Announces Price Target of $8
Piper Sandler analyst Matt O'Brien initiates coverage on Miromatrix Medical (NASDAQ:MIRO) with a Overweight rating and announces Price Target of $8.
Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology
Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, has received a new patent from the
Miromatrix Medical: Q2 Earnings Insights
Miromatrix Medical (NASDAQ:MIRO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell
• Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.